Business Wire

OpenLink Launches the First Comprehensive Trading, Treasury and Risk Cloud Platform

Del

OpenLink, the global leader in trading, treasury and risk management solutions for the energy, commodities, corporate and financial services industries, today announced the launch of OpenLink Cloud – the world’s first and most comprehensive enterprise Cloud platform for trading, treasury and risk management.

OpenLink Cloud is designed to transform trading, treasury and risk departments, combining the best of OpenLink’s flagship products with an extensible and transparent platform for unprecedented agility and innovation. Delivering the highest standards of security for highly regulated, data-intensive organizations, OpenLink Cloud combines the strength and security of the Microsoft Azure platform with best-of-breed OpenLink security and tools to ensure that our clients’ mission-critical systems and data are protected at all times.

Patrick Reames, Managing Partner of Commodity Technology Advisory the leading CTRM market analyst firm noted: “While Cloud deployment of commodity trading solutions in the low and mid-tiers of the market has increased in recent years, the investment by OpenLink in the OpenLink Cloud will undoubtedly accelerate this movement across all tiers of the market. The commitment by many of the world’s largest energy and commodity trading firms to adopt OpenLink’s enterprise-scale Cloud solutions is a pivotal development in terms of how these systems will be deployed going forward.”

Jack Large, Cash and Treasury Management Consultant and Analyst for CTMfile, said, “The wait is over. There is now enough power and security in the OpenLink Cloud to move mission critical systems to their Cloud platform, combined with OpenLink’s functional strength in cash and treasury management, extensive trading, commodities and risk management, could make this combination a game changer. Time will tell.”

Developed in collaboration with over 50 of OpenLink’s largest and most sophisticated energy and financial services clients, OpenLink Cloud has been rigorously tested by those who place the highest demands on the software. Supported by a robust set of custom tools and services, OpenLink Cloud is designed to help clients of all sizes get up and running quickly and to simplify management, monitoring and support of both production and non-production environments. Customers will have immediate access to almost limitless computing power with the introduction of OpenLink’s dynamic scaling capabilities, providing advanced data management and richer analytics that enable greater market understanding, speed and evidence-based decision-making.

John O’Malley, CEO of OpenLink, added: “If you think you knew OpenLink, take another look. We have made a significant investment in OpenLink Cloud in response to our clients’ feedback. They are looking to reduce costs, advance risk analytics and scale their operations to transform how they run their businesses. The response from clients and pent-up demand from prospects has been staggering. OpenLink Cloud enables us to deliver our market leading solutions faster and with attractive subscription pricing models.”

Scott Rompala, Head of the Cloud Solutions Group at OpenLink, said: “The real untapped benefit our clients are sharing is how this new flexibility and efficiency will allow them to reimagine their business, take advantage of intraday volatility in the markets, and provide accurate and real-time views of their risk and exposures to management and the board on demand.”

OpenLink Cloud facilitates calculations of P&L and VaR-type metrics more frequently and with broader data sets. These enhanced capabilities will enable departments to produce real-time analytics and improved hedging strategies, optimize capital movement and provide greater insight into profitability drivers, enhancing overall the information available for decision-making.

The OpenLink Cloud platform integrates an ecosystem of multiple tools and partners to provide a complete solution with comprehensive security, supported 24x7 by OpenLink Cloud experts. With new subscription-based pricing and dynamic scaling our clients can now better manage cost, risk and implement a platform for unrivalled innovation.

For further information please visit openlink.cloud

Contact information

Aspectus for OpenLink
Ellie Bacon (UK) / Bar Cudkevich (US)
+44 20 7242 8867 / +1 646 202 9845
openlink@aspectuspr.com
or
OpenLink
Michael Golding, +44 7766398912
Global Head of Public Relations
michael.golding@openlink.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom